Introducing AmgenNow™

AmgenNow is a program that makes certain Amgen medicines available directly to patients at a discounted monthly price. This program may benefit patients who are uninsured, in high-deductible health plans, or prefer to pay with cash or out of pocket.

At this time, Repatha^® (evolocumab) is available through the program. Other medicines may be available in the future.

• The AmgenNow program and patient discount coupon are open to all US patients with a valid qualifying prescription of Repatha^®, including those who are uninsured or in high-deductible health plans or prefer to pay with cash or out of pocket.
• This option will be available to all patients regardless of their insurance status, including those who participate in government programs such as Medicare and Medicaid.
• Prior authorization and step therapy is not required if a patient utilizes the discount coupon with a valid qualifying prescription of Repatha^®.
• To participate in this program, patients must agree that they are not using commercial or government insurance to obtain Repatha^® and will not attempt to claim or submit any costs associated with their Repatha^® prescription to their insurer. For patients enrolled in Medicare 
Part D, a Medicare Advantage prescription drug plan, or any other federal or state healthcare program (collectively, "government insurance"), patients must also agree to: 1) not seek reimbursement from their insurance for their out-of-pocket costs; 2) not to count the cost of their prescription toward their deductible or true out-of-pocket cost; 3) notify their insurer that their Repatha^® has been purchased outside of its prescription plan; and 4) purchase all Repatha^® prescriptions during the calendar year using this patient discount coupon program and not use their government insurance.

The patient presents the discount coupon available here, which includes a comprehensive list of participating pharmacies, and pays the cash-pay amount for their prescription.

If you want to leverage your commercial insurance for your Repatha^® prescription, you can enroll in the Repatha^® co-pay program here and may pay as little as $15 per month. Eligibility criteria and program maximums apply. Please see full Terms and Conditions at Repatha.com/copaytcs.

If you don't want to use your commercial insurance, you can use the AmgenNow program for Repatha^®. All eligibility requirements would apply and can be found here.

Patients can visit amgensupportplus.com/patient/repatha for more information.